相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PEGylation of therapeutic proteins
Simona Jevsevar et al.
BIOTECHNOLOGY JOURNAL (2010)
Peg-asparaginase for acute lymphoblastic leukemia
Michael Rytting
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness
Jun Huang et al.
NATURE (2010)
Update on emerging urate-lowering therapies
Saima Chohan et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Pegasparaginase: where do we stand?
Amer Zeidan et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
PEG-uricase in the management Of treatment-resistant gout and hyperuricemia
Merry R. Sherman et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Advances in laboratory evolution of enzymes
Shimon Bershtein et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Directed enzyme evolution via small and effective neutral drift libraries
Rinkoo D. Gupta et al.
NATURE METHODS (2008)
Protein therapeutics: A summary and pharmacological classification
Benjamin Leader et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Efficient production of membrane-integrated and detergent-soluble G protein-coupled receptors in Escherichia coli
A. James Link et al.
PROTEIN SCIENCE (2008)
A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
Peng Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Recent advances in antigen processing and presentation
Peter E. Jensen
NATURE IMMUNOLOGY (2007)
Evolution of a fluorinated green fluorescent protein
Tale Hyeon Yoo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
Neutral genetic drift can alter promiscuous protein functions, potentially aiding functional evolution
Jesse D. Bloom et al.
BIOLOGY DIRECT (2007)
Latent evolutionary potentials under the neutral mutational drift of an enzyme
Gil Amitai et al.
HFSP JOURNAL (2007)
Beyond toothpicks: new methods for isolating mutant bacteria
A. James Link et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab′
David J. Macfarlane et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
MHC class II proteins and disease: a structural perspective
EY Jones et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Drug therapy - Treatment of acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A β-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy
FA Harding et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer
NH Bander et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Antigen-specific memory B cell development
LJ McHeyzer-Williams et al.
ANNUAL REVIEW OF IMMUNOLOGY (2005)
A membrane metalloprotease participates in the sequential degradation of a Caulobacter polarity determinant
JC Chen et al.
MOLECULAR MICROBIOLOGY (2005)
Trends in enzyme therapy for phenylketonuria
W Kim et al.
MOLECULAR THERAPY (2004)
Elimination of an immunodominant CD4+ T cell epitope in human IFN-β does not result in an in vivo response directed at the subdominant epitope
VP Yeung et al.
JOURNAL OF IMMUNOLOGY (2004)
Engineering of a macromolecular scaffold to develop specific protease inhibitors
AA Stoop et al.
NATURE BIOTECHNOLOGY (2003)
A perspective on enzyme catalysis
SJ Benkovic et al.
SCIENCE (2003)
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
H Schellekens
CLINICAL THERAPEUTICS (2002)
Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies:: results of a randomized European Organisation for Research and Treatment of Cancer -: Children's Leukemia Group phase 3 trial
M Duval et al.
BLOOD (2002)
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia:: a Children's Cancer Group study
VI Avramis et al.
BLOOD (2002)
Engineering the substrate specificity of Escherichia coli asparaginase II.: Selective reduction of glutaminase activity by amino acid replacements at position 248
C Derst et al.
PROTEIN SCIENCE (2000)
分享论文
